Tandem Diabetes snags FDA approval for interoperable insulin pump software
Tandem Diabetes’ technology will create a new approval pathway for predictive dosing software that can be used with other devices.
Dexcom’s IT outage shows fabulous device maker floundering with patient communication
Scores of users took to Facebook to express their dismay, frustration and anger at Dexcom when the CGM device company failed to properly keep them updated after an IT outage prevented type 1 diabetes patients from sharing data.
presented by
Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software
Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.
Walgreens bolsters digital marketplace with new chronic disease management tools
Find Care, which was launched one year ago, was initially started to help patients find and identify location specific healthcare services through the Walgreens app and website.
When it comes to diabetes devices and apps, FDA prefers mixing and matching
On the day that an FDA official exhorts industry to develop interoperable diabetes devices, Medtronic announces that it is teaming up with a nonprofit group to do just that.
Connected device research platform Fitabase signs integration deal with Dexcom
Fitabase CEO Aaron Coleman said he sees the integration being particularly useful to researchers looking at how behavioral recommendations in areas like physical activity and sleep can affect glucose levels to create more tailored care plans for diabetic patients.
Dexcom’s first-gen CGM sensor developed with Verily won’t see light of day, at least in the U.S.
San Diego-based Dexcom said at the annual J.P. Morgan Healthcare Conference in San Francisco that it's first-gen product co-developed by Alphabet's Verily may never get launched in the U.S.
presented by
Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Medtronic acquires Israeli nutrition data startup Nutrino Health
Medtronic said the company will be rolled into its Diabetes Group to improve its diabetes management capabilities by adding Nutrino's comprehensive food database, food analysis system and nutrition-science expertise.
How CMS decided to ultimately cover a CGM connected to an iPhone
One episode shows how CMS evolved its thinking of how to cover continuous glucose monitoring when Medicare beneficiaries wanted to use it with their iPhones to share data with caregivers, family and physicians.
FDA clears new Dexcom CGM that requires no patient calibration earlier than expected
Months ahead of schedule, FDA clears the use of DexCom's latest continuous glucose monitoring system for patients two and up, freeing them from routine fingerstick calibration.
Medtronic’s MiniMed 670G insulin delivery system gave me peace of mind
After a Type 1 patient penned a post on why she didn't think Medtronic's 670G hailed as the first artificial pancreas was all that, another patient who uses the device writes it's exactly that and then some.
presented by
These Are the Top-Rated Autism Therapy Centers in Texas
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
Why I won’t be switching to Medtronic’s 670G insulin delivery system billed as the first artificial pancreas
As a type 1 diabetes patient, I have decided to stay on an open-source insulin delivery solution instead of switching to a hybrid closed-loop insulin delivery system from Medtronic whose FDA approval was widely hailed.
Dexcom shares take a hit as Abbott’s CGM system gets CMS nod
A sooner-than-expected availability of a rival's continuous glucose monitoring system to Medicare patients sends Dexcom's stocks lower, but an analyst believes this will be temporary.
Fitbit CEO details ambitions for diabetes management
Fitbit CEO and chairman James Park outlined the company's progress in a conference call late Wednesday to discuss the company's earnings in the third quarter.
New Abbott diabetes deal is a “missed opportunity” for DexCom
Abbott struck a deal with Bigfoot Medical by which the latter will use Abbott's glucose sensing technology to develop an artificial pancreas and not that of DexCom, the CGM market leader.
Dexcom will reap benefit as CMS posts criteria for Medicare coverage of CGMs
CMS announced its decision to cover continuous glucose monitoring sytems for Medicare patients in January, a big win for Dexcom.